The Clinical Stlldy Of The Treatment Of Jia Wei Shengyang Yiwei Decoction On Diarrhea-predominant Irritable Bowel Syndrome (The Type Of Liver Depression And Spleen Deficien)

Objective：This paper intends to improve contrast by clinical signs and symptoms,syndromes change efficacy evaluation, adverse reaction rates and relapse rates andother indicators to observe the Jiawei Shengyang Yiwei decoction effect ondiarrhea-predominant irritable bowel syndrome. Conduct scientific and objectiveassessment of its efficacy and its therapeutic mechanism described theoretically forChinese medicine treatment of diarrhea-predominant irritable bowel syndrome toprovide evidence.Methods：Choose met the inclusion criteria and by the exclusion of62patients afterstandard screening,31cases were randomly divided into treatment group and controlgroup31cases. The treatment group received treatment Jiawei Shengyang Yiweidecoction, various drugs are Luoyang City Second Hospital of herbs provide the partyroom, and a unified fried hospital extracting machine, one dose a day, morning andevening hours service, treatment1weeks. The control group received trimebutinemaleate tablets (DAC Miguel dimension),0.1g, orally, three times a day. Two recordsare one week for a course of treatment was observed2. And treatment of patients3months after the end of follow-up, the relapse rate of patients were compared.Changes in two groups of patients and clinical symptoms and signs of a return visitwhen serum5-HT levels observed before and after treatment and other aspects of thetherapeutic effect of two groups were compared.Results：1The study included62cases, after the end of the experiment the treatmentgroup of30patients in the control group of30patients (shedding two cases). Noformer general treatment, such as age, sex, duration and other aspects of a significantdifference (P>0.05), comparable.2TCM syndrome score comparion: After two weeks, the treatment group and the control group were valid. In addition to bowel vectorgas.the statistical analysis (P<0.05),there were significant differences statisticallysignificant,indicating improvement in the treatment group,in term of syndromes(except bowel vector gas outside)than the control group outside the role3monthsafter the end of treatment follow-up, patients were long-term efficacy statisticalanalysis,(P<0.05), the treatment group than the control group.3After treatment, theoverall efficacy of TCM comparision: the general aspects of the efficacy of traditionChinese medicine to improve the treatment group than the control group.Conclusion：1Recipe for Jiawei Shengyang Yiwei decoction can significantlyimprove the diarrhea-predominant irritable bowel syndrome (liver and spleendeficiency) in patients with bowel movements, diarrhea, abdominal pain, chestswelling, nausea, bowel, depression, irritability and other symptoms, can significantlyreduce the long-term relapse rate, clinical curative effect.2Recipe for JiaweiShengyang Yiwei decoction safety without significant side effects, inexpensive andworth promoting.